Endotoxin administration to humans provides a means to investigate mechanisms of human inflammation, proof of principle for the effects of inflammatory-modulating therapies, and serves as a potent stimulus to enhance immune responses in trials of immunotherapy for cancer. The Clinical Center provides GMP grade endotoxin to qualified investigators for these studies.

Anthony F. Suffredini, M.D.
ASuffredini@cc.nih.gov
301.402.3485

http://clinicalcenter.nih.gov/
about/SeniorStaff/
anthony_suffredini.html